Journal of Affective Disorders
Volume 70, Issue 2 , Pages 155-163 , July 2002

Does early intervention increase latency to relapse in major depressive disorder?: re-evaluation with cognitive behavior therapy

  • J.M Quiring

      Affiliations

    • Department of Psychology, University of Oregon, Eugene, OR 97403-1227, USA
    • Corresponding Author InformationCorresponding author
    • ,
  • S.M Monroe

      Affiliations

    • Department of Psychology, University of Oregon, Eugene, OR 97403-1227, USA
    • ,
  • A.D Simons

      Affiliations

    • Department of Psychology, University of Oregon, Eugene, OR 97403-1227, USA
    • ,
  • M.E Thase

      Affiliations

    • Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, USA

Received 15 August 2000 ,Accepted 9 February 2001.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980;
  2. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression: A Treatment Manual. New York: Guilford Press; 1979;
  3. Beck JS. Cognitive Therapy: Basics and Beyond. New York: Guilford Press; 1995;
  4. Cox DR, Oakes D. Analysis of Survival Data. New York: Chapman and Hill; 1984;
  5. DeRubeis RJ, Crits-Cristoph P. Empirically supported individual and group psychological treatments for adult mental disorders. J. Consult. Clin. Psychol. 1998;66:37–52
  6. Endicott J, Spitzer RL. A diagnostic interview: The Schedule of Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry. 1978;35:837–844
  7. Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Garvey MJ, Grove WM, et al. Differential relapse following cognitive therapy, pharmacotherapy, and combined cognitive-pharmacotherapy for depression. Arch. Gen. Psychiatry. 1992;49:802–808
  8. Gormley N, O’Leary DO, Costello F. First admissions for depression: Is the ‘no-treatment interval’ a critical predictor of time to remission?. J. Affect. Disord. 1999;54:49–54
  9. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  10. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and twelve-month prevalence of DSM III-R psychiatric disorders in the United States. Arch. Gen. Psychiatry. 1994;51:8–19
  11. Klerman GL. Depressive disorders: Further evidence for increased medical morbidity and impairment of social functioning. Arch. Gen. Psychiatry. 1989;46:856–858
  12. Klerman GL, Weissman MM. Increasing rates of depression. J. Am. Med. Assoc. 1989;261:2229–2235
  13. Kovacs M, Rush AT, Beck AT, Hollon SD. Depressed outpatients treated with cognitive therapy or pharmacotherapy: A one-year follow-up. Arch. Gen. Psychiatry. 1981;38:33–39
  14. Kraepelin E. Manic-Depressive Insanity and Paranoia. In:  Robertson GM editors. Edinburgh: E.S. Livingstone; 1921;R.M. Barclay, Translator
  15. Miller RG. Survival Analysis. New York: Wiley; 1981;
  16. Monroe SM, Simons AD, Thase ME. Onset of depression and time to treatment entry: roles of life stress. J. Consult. Clin. Psychol. 1991;59:566–573
  17. Murphy JM, Sobol AM, Neff RK, Oliver DC, Leighton AH. Stability of prevalence: Depression and anxiety disorders. Arch. Gen. Psychiatry. 1984;41:990
  18. Neimeyer RA, Baker KD, Haykal RF, Akiskal HS. Patterns of symptomatic change in depressed patients in a private inpatient mood disorders program. Bull. Menninger Clinic. 1995;59:460–471
  19. Nesse RM, Williams GC. Why We Get Sick. New York: Random House; 1994;
  20. Norusis MJ. SPSS Advanced Statistics 6.1. Chicago: SPSS; 1994;
  21. Post RM. Mechanisms underlying the evolution of affective disorders: implications for long-term treatment. In:  Grunhaus L,  Greden JF editor. Severe Depressive Disorders. Washington, DC: American Psychiatric Press; 1994;p. 23–65
  22. Post RM, Weiss SR, Leverich GS. Recurrent affective disorder: Roots in developmental neurobiology and illness progression based on changes in gene expression. Develop. Psychopathol. 1994;6:781–813
  23. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system: epidemiologic catchment area perspective 1-year prevalence rates of disorders in services. Arch. Gen. Psychiatry. 1993;50:85–94
  24. Roth A, Fonagy P. What Works For Whom?: A Critical Review of Psychotherapy Research. New York: Guilford Press; 1996;
  25. Simons AD, Murphy GE, Levine JL, Wetzel RD. Cognitive therapy and pharmacotherapy for depression: Sustained improvement over one year. Arch. Gen. Psychiatry. 1986;43:43–48
  26. Simons AD, Thase ME. Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: electroencephalographic sleep studies and response to cognitive therapy. J. Consult. Clin. Psychol. 1992;60:392–401
  27. Smith AL, Weissman MM. Epidemiology. In:  Paykel ES editors. Handbook of Affective Disorders. New York: Guilford Press; 1992;
  28. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Arch. Gen. Psychiatry. 1978;34:773–782
  29. Weissman MM, Bruce ML, Leaf PJ, Florio LP, Holzer C. Affective disorders. In:  Robbins LN,  Regier DA editor. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: Free Press; 1991;

PII: S0165-0327(01)00341-X

Journal of Affective Disorders
Volume 70, Issue 2 , Pages 155-163 , July 2002

Article Tools

* Image Usage & Resolution